The role of cell density and intratumoral heterogeneity in multidrug resistance

Cancer Research

Volumn 73, Issue 24, 2013, Pages 7168-7175

  Lavi, Orit ^a   Greene, James M ^b   Levy, Doron ^b   Gottesman, Michael M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Bldg 142   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL; CANCER CELL DESTRUCTION; CANCER GENETICS; CANCER RESISTANCE; CELL DENSITY; CELL FUNCTION; CONTROLLED STUDY; DNA MODIFICATION; EPIGENETICS; INTRATUMORAL HETEROGENEITY; MATHEMATICAL MODEL; MULTIDRUG RESISTANCE; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CELL COUNT; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 84891277447     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-1768     Document Type: Article

References (24)

1. Fodale V, Pierobon M, Liotta L, Petricoin E. Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance Cancer J 2011;17:89-95.
2. Gillet JP, Gottesman MM. Mechanisms of multidrug resistance in cancer. Methods Mol Biol 2010;596:47-76.
3. Saunders NA, Simpson F, Thompson EW, Hill MM, Endo-Munoz L, Leggatt G, et al. Role of intratumoural heterogeneity in cancer drug resistance: Molecular and clinical perspectives. EMBO Mol Med 2012;4:675-84.
4. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008;135:510-23.
5. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009;459:428-32.
6. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C, et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011;146:633-44.
7. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010;141:69-80.
8. Kreso A, O'Brien CA, van Galen P, Gan OI, Notta F, Brown AM, et al. Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 2013;339:543-8.
9. Marusyk A, Polyak K. Cancer. Cancer cell phenotypes, in fifty shades of grey. Science 2013;339:528-9.
10. Robey RW, Massey PR, Amiri-Kordestani L, Bates SE. ABC transporters: Unvalidated therapeutic targets in cancer and the CNS. Anticancer Agents Med Chem 2010;10:625-33.
11. McFarland CD, Korolev KS, Kryukov GV, Sunyaev SR, Mirny LA. Impact of deleterious passenger mutations on cancer progression. Proc Natl Acad Sci U S A 2013;110:2910-5.
12. Buchholz TA, Davis DW, McConkey DJ, Symmans WF, Valero V, JhingranA, et al.Chemotherapy-inducedapoptosisandBcl-2levelscorrelate with breast cancer response to chemotherapy. Cancer J 2003;9:33-41.
13. Wong KK. Recent developments in anti-cancer agents targeting the Ras/Raf/ MEK/ERK pathway. Recent Pat Anticancer Drug Discov 2009;4:28-35.
14. Koi M, Boland CR. Tumor hypoxia and genetic alterations in sporadic cancers. J Obstet Gynaecol Res 2011;37:85-98.
15. Lavi O, Gottesman MM, Levy D. The dynamics of drug resistance: A mathematical perspective. Drug Resist Updat 2012;15:90-7.
16. Lorz A, Lorenzi T, Hochberg ME, Clairambault J, Perthame B. Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies. ESAIM-Math Model Num Analysis 2013;47:377-99.
17. Lewis K. Persister cells, dormancy, and infectious disease. Nat Rev Microbiol 2007;5:48-56.
18. Tutt AN, van Oostrom CT, Ross GM, van Steeg H, Ashworth A. Disruption of Brca2 increases the spontaneous mutation rate in vivo: Synergism with ionizing radiation. EMBO Rep 2002;3:255-60.
19. Klein TJ, Glazer PM. The tumor microenvironment and DNA repair. Semin Radiat Oncol 2010;20:282-7.
20. Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res 1996;56:5754-7.
21. Rando OJ, Verstrepen KJ. Timescales of genetic and epigenetic inheritance. Cell 2007;128:655-68.
22. Shen H, Laird PW. Interplay between the cancer genome and epigenome. Cell 2013;153:38-55.
23. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012;366:883-92.
24. Hodgkinson A, Eyre-Walker A. Variation in the mutation rate across mammalian genomes. Nat Rev Genet 2011;12:756-66.